MR evaluation of adrenal masses at 1.5 T

Department of Radiology, Duke University Medical Center, Durham, NC 27710.

We retrospectively studied the value of MR imaging at 1.5 T to distinguish between nonadenomatous (n = 17) and adenomatous (n = 15) adrenal masses on the basis of (1) signal-intensity ratios on T1- and T2-weighted spin-echo images, (2) T2 relaxation times, and (3) T2 relaxation-time ratios. Univariate and then multivariate logistic regression were applied to these quantitative parameters to determine which of these best discriminated nonadenomas from adenomas, and whether or not more than one of these parameters improved the prediction. The adrenal mass/liver signal-intensity ratio on T2-weighted spin-echo images could not be used to differentiate nonadenomas from adenomas. Adrenal mass/fat signal-intensity ratios on T2-weighted spin-echo images, adrenal/liver T2 relaxation-time ratios, and adrenal mass T2 relaxation times were best for distinguishing nonadenomas from adenomas. By using a T2 value of greater than 61 msec, the true-positive ratio/false-positive ratio of differentiating nonadenomas from adenomas was 100%/20%; at greater than 82 msec, it was 64%/0.06%. The adrenal mass/fat signal-intensity ratios on T2-weighted spin-echo images and the adrenal/liver T2 relaxation-time ratios showed similar inherent discriminatory capacity. Overlap remains despite the use of these parameters. On the basis of this preliminary information, we conclude that MR has merit for the characterization of adrenal masses at 1.5 T. T2 relaxation time of the adrenal mass shows the greatest promise for discriminating nonadenomas from adenomas.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. Ilias and K. Pacak Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 479 - 491. [Full Text] [PDF]

				D. P. Saurborn, J. B. Kruskal, I. E. Stillman, and S. Parangi Best Cases from the AFIP: Paraganglioma of the Organs of Zuckerkandl RadioGraphics, September 1, 2003; 23(5): 1279 - 1286. [Full Text] [PDF]

				L. Yao, T. Namimoto, Y. Yamashita, K. Mitsuzaki, Y. Nakayama, O. Makita, M. Katoda, and M. Takahashi Routine Opposed-Phase FLASH MR Imaging Does Not Quantify Fat Content Drs Namimoto and colleagues respond: Radiology, October 1, 2001; 221(1): 274 - 274. [Full Text] [PDF]

				D. G. Mitchell Evaluating the impact of magnetic resonance imaging on patients with operable non-small-cell lung cancer and unilateral adrenal masses: Importance of appropriate technique J. Thorac. Cardiovasc. Surg., April 1, 1995; 109(4): 814 - 815. [Full Text]

				M. Burt, R. T. Heelan, D. Coit, P. M. McCormack, M. S. Bains, N. Martini, V. Rusch, and R. J. Ginsberg Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancerImpact of magnetic resonance imaging J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 584 - 589. [Abstract] [Full Text]